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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A198using hip and knee replacement data from Alberta, Canada, over a 10
year period and knee replacements recorded in the Swedish Knee
Arthroplasty Register (SKAR) over 24 years. We recommend a pre-
ferred method for accurately estimating the cumulative incidence of
revision that can be used to inform health policy decisions and future
resource allocation.
Methods: We measured the time to revision, death, or censoring for
cohorts of uncemented total hip (n¼12,496) and cemented total knee
arthroplasties (TKAs) (n¼19,172) recorded in administrative inpatient
databases in Alberta from 2003 to 2013 and cemented TKAs
(n¼80,177) recorded in the SKAR from 1989 to 2012. Each cohort
included primary unilateral procedures in patients with osteoarthritis.
We estimated the unadjusted cumulative incidence of revision using
the KM failure function (1-KM) and the cumulative incidence function
(CIF), which accounts for competing risks. To quantify the over-
estimation of the KM method compared to the CIF, we calculated the
relative difference (RD) ([{1-KM}-CIF]/CIF) between estimates at ﬁve,
nine, and 23 years (Swedish knee cohort only) following primary
surgery. We also compared three regression models that accounted for
competing risks: the Cox proportional hazards model, Fine and Gray
subdistribution hazards model, and Royston and Parmar ﬂexible
parametric model. We adjusted for age, sex, Charlson Comorbidity
Score (Alberta cohorts only) and year of primary operation (Swedish
cohort only). To examine differences between regression models, we
compared the magnitude of coefﬁcients (hazard ratio [HR] for the Cox
and Royston and Parmar models, subdistribution HR for the Fine and
Gray model), standard errors (SE), and Wald statistic P-values. Our
base case analysis included primary unilateral operations only. In
sensitivity analysis, we included unilateral and staged-bilateral oper-
ations to compare the performance of each model using larger sample
sizes and where the assumption of independence between subjects
was violated.
Results: The KM method and CIF produced similar estimates at fol-
low-up times shorter than 10 years for all three cohorts, although the
KM cumulative incidence was greater than the CIF at each time point.
The magnitude of overestimation at each follow-up time was greatest
for the Swedish cohort, which also had the highest cumulative inci-
dence of death. The extent of overestimation also increased with
follow-up time and became substantial beyond 10 years. At ﬁve years,
the relative increase in estimation of the cumulative incidence esti-
mated using the KM method compared to the CIF for the Alberta hip,
Alberta knee, and Swedish knee cohorts was 1.8%, 2.3%, and 3.8%,
respectively. At nine years, the RDs increased to 3.1%, 5.8%, and 8.2%,
respectively. At 23 years, the RD for the Swedish cohort reached 39.1%,
where the cumulative incidence estimated using the KM method was
7.4% compared to 5.3% for the CIF. Each adjusted regression model
yielded similar coefﬁcients, SEs, and P-values for our base caseTable 1. Six-month Medication and Nutraceutical Costs by Demographic and Clinical
N Medication Cost (US dollar)
Median P25 P75
All 204 962 151 2,781
Gender
Male 61 905 153 4,387
Female 143 991 151 2,491
Race
White 107 911 181 3,061
Black 72 989 212 2,697
Asian 6 177 9 318
Other 19 1,046 0 3,893
WOMAC Pain Score (0-500)
Tertile 1 (least pain) 68 1,018 137 2,491
Tertile 2 68 909 108 2,595
Tertile 3 (most pain) 67 1,013 223 3,646
WOMAC Function Score (0-1700)
Tertile 1 (most function) 68 1,064 164 3,161
Tertile 2 68 962 47 2,871
Tertile 3 (least function) 68 878 234 2,577
Beck II Score (0-63)
13 (no depression) 163 849 135 2,489
 14 (depression) 41 1,312 332 5,214analysis. However, in our sensitivity analysis the Fine and Gray sub-
distribution HR for sex deviated from the HRs obtained from the Cox
and Royston and Parmar models (P¼0.365, P¼0.039, P¼0.045,
respectively).
Conclusions: Our results support the application of the CIF and com-
peting risks regression models to more accurately estimate the cumu-
lative incidence of revision following joint replacement surgery.
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Purpose: For the pain and physical function limitations from knee
osteoarthritis (OA), we have previously reported that both pain and
non-pain medications and nutraceuticals (i.e., dietary supplements)
were more commonly used by patients enrolled in our randomized
clinical trial than that reported in the Osteoarthritis Initiative (Arthritis
Research & Therapy 2013, 15:R106). The aim of this analysis was to
determine the economic cost of those medications and nutraceutical
products and to assess the association of patient demographic and
clinical characteristics with costs.
Methods: Using the Health Assessment Questionairre (HAQ) health
utilization form, persons whomet ACR criteria for knee OA patients and
enrolled in a Tai Chi versus physical therapy for knee osteoarthritis trial
reported their use of prescription and over-the-counter medications
and nutraceutical products during the prior 6 months. Costs were
assigned using the average wholesale price (AWP) from Micromedex
2.0 Red Book Online for medications and ConsumerLab.com® or Ama-
zon for nutraceuticals. Costs accounted for dose and frequency. Because
the distributions of medication and nutraceutical costs were skewed,
we report median and interquartile range (IQR) summary descriptive
results and performed generalized linear model (GLM) regression with
log link function. All p-values were two tailed.
Results: In the 204 knee OA patients included in the present analysis
(mean age 60.2 years, 70% female, mean±SDWOMAC pain 254±95 and
WOMAC function 899±352). 157 (77%), 166 (81%), 150 (74%) reported
taking at least one pain, non-pain medication, or nutraceutical (7%
glucosamine), respectively. Each patient used a median of 4 (IQR: 2-6)
medications and 2 (IQR: 0-4) nutraceutical products. Estimated 6-
month costs for medications and nutraceuticals were $962 (IQR: $152-
$2,781) and $27 (IQR: $0-$86), respectively, yielding a combined total
cost of $989 (IQR: $240-$2,865). The Table summarizes the estimated 6-
month medication and nutraceutical costs by demographic and clinicalCharacteristics
Nutraceutical Cost (US dollar) Total Cost (US dollar)
Median P25 P75 Median P25 P75
27 0 86 989 241 2,865
24 0 75 905 177 4,387
33 2 106 1,004 252 2,745
47 16 122 1,004 261 3,123
22 0 64 989 287 2,719
24 0 38 201 27 1,086
15 0 68 1,113 106 3,953
46 22 111 1,031 257 2,674
24 0 86 909 226 2,643
22 0 62 1,029 261 3,661
37 18 100 1,121 250 3,223
24 0 86 1,027 141 2,993
22 0 75 878 336 2,610
29 0 88 905 228 2,540
24 0 77 1,363 374 5,251
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A199characteristics. Univariate GLM regression showed that medication
costs were 45% lower in women (p¼0.008) than in men, 83% lower in
Asians thanwhites, and 99% lower in patients without depression (Beck
II Score 13) than in those with mild to severe depression (p¼0.002).
While there were no signiﬁcant differences in nutraceutical cost
between women and men, nutraceutical costs were 53% and 75% lower
in blacks (p¼0.001) and Asians (p¼0.02) than in whites. In addition,
although age was not signiﬁcantly associated with medication costs,
older age was associated with higher nutraceutical costs (p¼0.04).
Moreover, higher nutraceutical costs were associated with less pain
(p¼0.002) and better function (p¼0.03).
After controlling for age and sex, higher medication cost was associated
with having depression (Beck II Score14) (p<0.001) but not associated
with WOMAC pain or function. In contrast, higher nutraceutical cost
was not associated with depression but was associated with improved
WOMAC pain (p¼0.009) and function (p¼0.05). (Figures 1 & 2)
Conclusions: Older knee OA patients in our clinical trial incur a sub-
stantial economic burden from medications. Nutraceutical use was
associated with less pain and improved function with lower costs
compared with medications suggesting a potential role in knee OA
symptom management.
Figure 1. Six-month Medication Costs by WOMAC pain scores, Beck II
scores, and Gender.
Figure 2. Six-month Nutraceutical Costs by WOMAC pain scores, Beck II
scores, and Gender.315
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Purpose: Given the chronic nature of osteoarthritis (OA) and limited
healthcare resources, effective disease-related education and ongoing
self-management are essential. However, preferences for OA education
and support are poorly understood and the uptake of structured pro-
grams is low. Many of the reasons for non-participation (including work
and family responsibilities) are particularly relevant to young people.
Our recent research has comprehensively documented the signiﬁcant
impact of hip and knee OA on young people, and the need to adequately
support and educate this group is clear. As part of this research, we also
sought to investigate preferences for OA education and support. This
study aimed to explore the perceived utility and accessibility of differ-
ent models of disease-related education and support among young
people with OA.
Methods: People aged 20-55 years with hip or knee OA were recruited
from 3 major public hospitals in the state of Victoria, Australia
(n¼126) and from the community (n¼21). The study questionnaire
collected data on previous use of disease-related education and sup-
port services, and the perceived utility and accessibility of a range of
models including group-based programs, online resources, telephone
helplines, social media (Facebook/Twitter) and applications for port-
able devices. Participants responded to the question ‘How useful
would the following methods of providing education and support be
for you?’ on a visual analogue scale (VAS) ranging from 1 (not at all
useful) to 10 (extremely useful) in relation to each model. Perceived
accessibility was assessed using the question ‘How easy would it be
for you to access education about your hip or knee osteoarthritis or
support using the following methods?’ Participants responded to this
question on a VAS from 1 (very difﬁcult) to 10 (very easy). All data
were analysed descriptively.
Results: Very few participants had attended a group-based arthritis
or chronic disease self-management program (2%), or called a tele-
phone helpline (2%) to obtain information about their OA. While
36% of the sample (n¼53) had used online resources such as
arthritis consumer organisation websites, government health
information websites and research databases, relatively few (5%)
had accessed social media (such as Facebook or Twitter) with regard
to their OA.
Overall, participants considered mailed information packs and online
education programs to be the most useful methods for providing edu-
cation and support (median perceived utility scores 8.0 and 7.0,
respectively). Almost one-third of participants (n¼42, 29%) considered
that mailed information packs would be ‘extremely useful’ to them.
Social media was deemed the least useful of the models evaluated
(median perceived utility score 2.0), with 45% of participants (n¼66)
reporting it would be ‘not at all useful’ for providing them with edu-
cation and support.
Mailed information packs, online education programs and telephone
helplines were perceived to be the easiest ways of accessing OA-
related education and support (median perceived accessibility scores
10.0, 9.0 and 8.0, respectively). Half of the sample (n¼74, 50%) con-
sidered that it would be ‘very easy’ for them to access education about
their hip or knee OA using mailed information packs. Group-based
self-management programs and social media had the lowest perceived
accessibility (median perceived accessibility scores 5.0 and 4.5,
respectively). Thirty-ﬁve per cent of participants (n¼51) considered it
would be ‘very difﬁcult’ for them to access OA education or support
via social media.
Conclusions: These preference data highlight the value of mailed
information and online education to young people with OA, and can be
